Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) shares traded up 3.7% on Monday . The company traded as high as $6.83 and last traded at $6.83. 691 shares were traded during mid-day trading, a decline of 47% from the average session volume of 1,299 shares. The stock had previously closed at $6.5848.
Aspen Pharmacare Price Performance
The company has a current ratio of 2.21, a quick ratio of 1.18 and a debt-to-equity ratio of 0.37. The business has a fifty day moving average price of $5.64 and a 200 day moving average price of $5.97.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Recommended Stories
- Five stocks we like better than Aspen Pharmacare
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- The $100 Trillion AI Story No One Is Telling You
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
